European Analysts Ranked for Quality of Research
Research Excellence
Piper Jaffray analysts were ranked highly in the 2007 Thomson Extel Pan-European Survey, an annual list distinguishing the top analysts and firms for the quality of their research. More than 250 firms were eligible for inclusion on the list, which was voted on by European fund managers.
Senior research analyst, Sam Fazeli was ranked number two out of more than 15 analysts in the UK Small Caps: Life Sciences sector. Fazeli covers European biopharmaceutical companies where he has more than 10 years of experience.
Overall, Piper Jaffray ranked third in the UK Small Caps: Life Sciences category and ranked eighth in the Biotechnology category.
“We provide worldwide proprietary and quality research for our clients,” said David Wilson, CEO of Piper Jaffray Ltd. “We are delighted that the high standard of our analysts and their research has been recognised by fund managers.”